2B70.DE vs. W311.DE
2B70.DE (iShares Nasdaq US Biotechnology UCITS ETF) and W311.DE (HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF) are both Health & Biotech Equities funds - 2B70.DE tracks the Nasdaq Biotechnology while W311.DE tracks the Indxx Global NextGen Healthcare. Both are passively managed. Over the past 5 years, 2B70.DE returned 5.68%/yr vs -5.98%/yr for W311.DE. A 0.79 correlation means they provide meaningful diversification when combined. 2B70.DE charges 0.35%/yr vs 0.59%/yr for W311.DE.
Performance
2B70.DE vs. W311.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, 2B70.DE achieves a 4.53% return, which is significantly higher than W311.DE's -3.63% return.
2B70.DE
- 1D
- 3.29%
- 1M
- 1.98%
- YTD
- 4.53%
- 6M
- 3.42%
- 1Y
- 39.14%
- 3Y*
- 10.00%
- 5Y*
- 5.68%
- 10Y*
- —
W311.DE
- 1D
- 3.38%
- 1M
- 1.65%
- YTD
- -3.63%
- 6M
- -6.55%
- 1Y
- 11.17%
- 3Y*
- -2.49%
- 5Y*
- -5.98%
- 10Y*
- —
2B70.DE vs. W311.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF | 4.53% | 18.62% | 4.60% | 2.56% | -6.29% | 7.59% | 14.52% | 15.56% |
W311.DE HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF | -3.63% | 7.18% | -4.84% | -0.30% | -25.93% | 1.52% | 14.63% | 15.38% |
Correlation
The correlation between 2B70.DE and W311.DE is 0.81, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.81 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.77 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.78 |
Correlation (All Time) Calculated using the full available price history since May 3, 2019 | 0.79 |
The correlation between 2B70.DE and W311.DE has been stable across timeframes, ranging from 0.77 to 0.81 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
2B70.DE vs. W311.DE — Risk / Return Rank
2B70.DE
W311.DE
2B70.DE vs. W311.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF (W311.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| 2B70.DE | W311.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.45 | ||
| Sortino ratioReturn per unit of downside risk | +1.92 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.11 | +0.23 |
| Calmar ratioReturn relative to maximum drawdown | 6.15 | 0.69 | +5.46 |
| Martin ratioReturn relative to average drawdown | 17.06 | 1.61 | +15.45 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| 2B70.DE | W311.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.04 | 0.59 | +1.45 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.28 | -0.26 | +0.54 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.36 | -0.02 | +0.37 |
Drawdowns
2B70.DE vs. W311.DE - Drawdown Comparison
The maximum 2B70.DE drawdown since its inception was -30.87%, smaller than the maximum W311.DE drawdown of -48.92%. Use the drawdown chart below to compare losses from any high point for 2B70.DE and W311.DE.
Loading charts...
Drawdown Indicators
| 2B70.DE | W311.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.87% | -48.92% | +18.05% |
Max Drawdown (1Y)Largest decline over 1 year | -6.33% | -16.09% | +9.76% |
Max Drawdown (3Y)Largest decline over 3 years | -29.34% | -28.36% | -0.98% |
Max Drawdown (5Y)Largest decline over 5 years | -30.87% | -48.92% | +18.05% |
Current DrawdownCurrent decline from peak | -1.26% | -35.40% | +34.14% |
Average DrawdownAverage peak-to-trough decline | -10.01% | -23.20% | +13.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.29% | 6.93% | -4.64% |
Volatility
2B70.DE vs. W311.DE - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) has a higher volatility of 6.65% compared to HANetf HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF (W311.DE) at 6.31%. This indicates that 2B70.DE's price experiences larger fluctuations and is considered to be riskier than W311.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| 2B70.DE | W311.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.65% | 6.31% | +0.34% |
Volatility (6M)Calculated over the trailing 6-month period | 14.26% | 13.92% | +0.34% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.09% | 18.96% | +0.13% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.34% | 22.38% | -2.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.76% | 22.73% | -0.97% |
2B70.DE vs. W311.DE - Expense Ratio Comparison
2B70.DE has a 0.35% expense ratio, which is lower than W311.DE's 0.59% expense ratio.
Dividends
2B70.DE vs. W311.DE - Dividend Comparison
Neither 2B70.DE nor W311.DE has paid dividends to shareholders.
Frequently Asked Questions
2B70.DE and W311.DE have a correlation of 0.81, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, 2B70.DE is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
2B70.DE is cheaper with a 0.35% expense ratio, compared with 0.59% for W311.DE.
2B70.DE tracks Nasdaq Biotechnology, while W311.DE tracks Indxx Global NextGen Healthcare. They also come from different issuers: iShares and HANetf. Their fees differ too: 0.35% for 2B70.DE and 0.59% for W311.DE.
Find the right allocation for 2B70.DE and W311.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer